John Prufeta

Aetna, Inc. engages in the provision of traditional, voluntary, and consumer-directed health insurance products and related services. It offers benefits, products and services to individuals, employers, healthcare professionals, and producers. The company was founded by Eliphalet Adams Bulkeley in 1853 and is headquartered in Hartford, CT.

Ramp Corp. develops and markets the CareGiver and CarePoint suite of technologies through its wholly-owned subsidiary HealthRamp. Its technologies enable medical professionals and institutions to easily access, capture, and share critical medical information directly at the point-of-care. The company's technology CareGiver, a long term care facility staff to easily place orders for drugs, treatments and supplies from a wireless handheld PDA or desktop web browser and CarePoint, an electronic prescribing, lab orders & results, Internet-based communication, data integration and transaction processing over a handheld device at the point-of-care. It focuses on providing physicians and other healthcare providers with a low-cost, easily adopted, narrowly defined set of technologies, whose primary functionality is currently centered on electronic prescribing. The company's products enable communication of value-added healthcare information among physician offices, pharmacies, hospitals, pharmacy benefit managers, health management organizations, pharmaceutical companies and health insurance companies.

NewYork-Presbyterian Hospital offers healthcare services. Its services include surgery, corporate health, nephrology, dermatology, cardiology, hepatology, vascular care, emergency care, and ambulatory care. The company was founded in 1771 and is headquartered in New York, NY.

OnPoint Partners, Inc. provides staffing and recruiting services. It offers health care, financial services, insurance and technology industries. The company was founded by John R. Prufeta in 1989 and is headquartered in Carle Place, NY.

Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City.

ProJenX, Inc. is a clinical-stage biotechnology company that focuses on developing targeted therapies for untreatable brain diseases, with a particular emphasis on ALS. The company is based in Nissequogue, NY. ProJenX's lead therapy candidate, Prosetin, is a first-in-class kinase inhibitor that is being developed for people living with ALS. The company's innovative, patient-specific, cell-based drug discovery platform is at the heart of its approach to research and drug development for ALS and other debilitating brain diseases. The company was founded in 2021 by Erin Fleming and Valerie Estess, and the CEO is Stan E. Abel.